~$330KReported value · 1,274 sh @ $259.07
Stock since the trade +8.0% · S&P 500 -0.6% · to Oct 1
Charles River Laboratories's SVP, Finance and CAO sold $330K of Charles River Laboratories shares. Nobody planned it ahead of time.
CSVP, CAO, Interim CFO
Disclosures on record
23
Companies involved
1
Stock since the trade +8.0% · S&P 500 -0.6% · to Oct 1
Charles River Laboratories's SVP, Finance and CAO sold $330K of Charles River Laboratories shares. Nobody planned it ahead of time.
Stock since the trade +8.0% · S&P 500 -0.6% · to Oct 1
Charles River Laboratories's SVP, Finance and CAO sold $312K of Charles River Laboratories shares. Nobody planned it ahead of time.
Stock since the trade +8.0% · S&P 500 -0.6% · to Oct 1
Charles River Laboratories's SVP, Finance and CAO sold $235K of Charles River Laboratories shares. Nobody planned it ahead of time.
Stock since the trade +8.0% · S&P 500 -0.6% · to Oct 1
Charles River Laboratories's SVP, Finance and CAO sold $212K of Charles River Laboratories shares. Nobody planned it ahead of time.
Stock since the trade +8.0% · S&P 500 -0.6% · to Oct 1
Charles River Laboratories's SVP, Finance and CAO sold $190K of Charles River Laboratories shares. Nobody planned it ahead of time.
Stock since the trade +8.0% · S&P 500 -0.6% · to Oct 1
Charles River Laboratories's SVP, Finance and CAO sold $164K of Charles River Laboratories shares. Nobody planned it ahead of time.
Stock since the trade +8.0% · S&P 500 -0.6% · to Oct 1
Charles River Laboratories's SVP, Finance and CAO sold $128K of Charles River Laboratories shares. Nobody planned it ahead of time.
Stock since the trade +8.0% · S&P 500 -0.6% · to Oct 1
Charles River Laboratories's SVP, Finance and CAO sold $104K of Charles River Laboratories shares. Nobody planned it ahead of time.
Stock since the trade +8.0% · S&P 500 -0.6% · to Oct 1
Charles River Laboratories's SVP, Finance and CAO sold $56K of Charles River Laboratories shares. Nobody planned it ahead of time.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Compensation award — excluded from discretionary-purchase analysis.
Routine share withholding; mechanical by default.
Routine share withholding; mechanical by default.
Routine share withholding; mechanical by default.
Routine share withholding; mechanical by default.
Compensation award — excluded from discretionary-purchase analysis.
Routine share withholding; mechanical by default.
Compensation award — excluded from discretionary-purchase analysis.